We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-15.94%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$58.5M
AUM Growth
-$18.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
1
Akebia Therapeutics
AKBA
$354M
$18.5M 31.57%
16,205,119
ANNX icon
2
Annexon
ANNX
$834M
$16.7M 28.46%
7,056,024
AMWL icon
3
American Well
AMWL
$180M
$12.3M 20.95%
523,786
WHWK
4
Whitehawk Therapeutics
WHWK
$190M
$7.89M 13.49%
1,630,830
ASMB icon
5
Assembly Biosciences
ASMB
$498M
$1.97M 3.37%
185,625
RNTX
6
Rein Therapeutics
RNTX
$63.1M
$1.26M 2.16%
830,466

Similar funds

Alerce Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Alerce Investment Management held 6 positions worth $58.5M, down 24% from $76.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. Alerce Investment Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's ten largest holdings make up 100% of its $58.5M portfolio in Q3 2023.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q3 2023.
  • Alerce Investment Management's portfolio value fell 24% quarter-over-quarter to $58.5M.

Based on Alerce Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.